ELP4 Activators
The class of ELP4 Activators encompasses a variety of chemical compounds that could modulate the functional activity of ELP4, a component of the Elongator complex, by influencing transcriptional elongation, tRNA modification, and related cellular processes. Agents like Trichostatin A, Vorinostat, and Sodium Butyrate, which are histone deacetylase inhibitors, could indirectly enhance ELP4 activity by altering chromatin structure and accessibility, thereby affecting transcriptional regulation processes in which ELP4 is implicated. These changes in chromatin dynamics could lead to an environment more conducive to the transcriptional elongation functions of the Elongator complex.
Moreover, compounds like 5-Azacytidine and S-Adenosylmethionine target epigenetic mechanisms-DNA methylation and methylation of other substrates, respectively. These modifications could indirectly impact the role of ELP4 in transcriptional regulation and tRNA modification. Additionally, compounds like Caffeine, Nicotinamide, Curcumin, and Beta-Estradiol, which affect various cellular signaling and metabolic pathways, might indirectly influence the functional activity of ELP4 through broader impacts on cellular transcriptional landscapes and gene expression regulation. This indirect modulation could stem from alterations in cellular signaling pathways, such as those governed by PI3K, as targeted by LY294002, or mTOR, as targeted by Rapamycin. These pathways are integral to various aspects of cell growth and metabolism, which intersect with the transcriptional and translational machinery of the cell.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
As a histone deacetylase inhibitor, TSA might enhance ELP4 activity indirectly by modifying chromatin structure, affecting transcription. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
A DNA methyltransferase inhibitor, could influence ELP4 activity by altering DNA methylation patterns, indirectly affecting transcription. | ||||||
Ademetionine | 29908-03-0 | sc-278677 sc-278677A | 100 mg 1 g | $184.00 $668.00 | 2 | |
As a methyl donor, it could indirectly influence ELP4 function in tRNA modification and thus affect translation efficiency. | ||||||
Caffeine | 58-08-2 | sc-202514 sc-202514A sc-202514B sc-202514C sc-202514D | 50 g 100 g 250 g 1 kg 5 kg | $33.00 $67.00 $97.00 $192.00 $775.00 | 13 | |
Known to affect various signaling pathways, caffeine might indirectly influence ELP4 activity through cellular signaling changes. | ||||||
Nicotinamide | 98-92-0 | sc-208096 sc-208096A sc-208096B sc-208096C | 100 g 250 g 1 kg 5 kg | $44.00 $66.00 $204.00 $831.00 | 6 | |
As a NAD+ precursor, it could affect ELP4 function indirectly by influencing cellular metabolism and related transcription processes. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
Another histone deacetylase inhibitor, could impact ELP4 activity by altering chromatin accessibility and transcriptional regulation. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Affects gene expression; could indirectly influence ELP4 activity in the context of transcriptional regulation. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
A histone deacetylase inhibitor, could affect chromatin structure and thus influence ELP4's role in transcriptional elongation. | ||||||
β-Estradiol | 50-28-2 | sc-204431 sc-204431A | 500 mg 5 g | $63.00 $182.00 | 8 | |
A hormone known to influence gene expression, could indirectly impact ELP4 activity through estrogen receptor-mediated transcription. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A PI3K inhibitor; might indirectly influence ELP4 by modulating signaling pathways that intersect with transcriptional regulation. | ||||||